Incidence and outcome of BCR-ABL mutated chronic myeloid leukemia patients who failed to tyrosine kinase inhibitors.

Gabriel Etienne,Stéphanie Dulucq,Françoise Huguet,Anna Schmitt,Axelle Lascaux,Sandrine Hayette,Marie-Pierre Fort,Pierre Sujobert,Fontanet Bijou,Stéphane Morisset,Suzanne Tavitian,Audrey Bidet,Beatrice Turcq,Fanny Robbesyn,Claudine Chollet,Francis Belloc,Françoise Durrieu,François-Xavier Mahon,Franck E Nicolini

CANCER MEDICINE（2019）

引用 15|浏览105

暂无评分

关键词

BCR-ABL kinase domain mutation,chronic myeloid leukemia,tyrosine kinase inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要